MENU
+Compare
ALT
Stock ticker: NASDAQ
AS OF
Mar 17 closing price
Price
$5.97
Change
+$0.05 (+0.84%)
Capitalization
455.92M

ALT Altimmune Forecast, Technical & Fundamental Analysis

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases... Show more

ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ALT with price predictions
Mar 17, 2025

ALT's Indicator enters downward trend

The Aroon Indicator for ALT entered a downward trend on March 17, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 279 similar instances where the Aroon Indicator formed such a pattern. In of the 279 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALT as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for ALT moved below the 200-day moving average on February 26, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ALT's RSI Oscillator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where ALT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ALT just turned positive on March 17, 2025. Looking at past instances where ALT's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ALT advanced for three days, in of 299 cases, the price rose further within the following month. The odds of a continued upward trend are .

ALT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ALT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.723) is normal, around the industry mean (13.581). P/E Ratio (0.000) is within average values for comparable stocks, (64.417). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.816). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. ALT's P/S Ratio (10000.000) is very high in comparison to the industry average of (240.384).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ALT is expected to report earnings to rise 11.73% to -36 cents per share on May 08

Altimmune ALT Stock Earnings Reports
Q1'25
Est.
$-0.37
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.04
Q2'24
Est.
$-0.35
Q1'24
Beat
by $0.04
The last earnings report on February 27 showed earnings per share of -33 cents, beating the estimate of -34 cents. With 5.88M shares outstanding, the current market capitalization sits at 455.92M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Miscellaneous Commercial Services
Address
910 Clopper Road
Phone
+1 240 654-1450
Employees
59
Web
https://www.altimmune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRVRX16.92N/A
N/A
Nuveen Mid Cap Value Retire
FCIGX30.33N/A
N/A
Fidelity Advisor Small Cap Growth I
VSSVX10.67N/A
N/A
VALIC Company I Small Cap Special Val
PJVQX22.14N/A
N/A
PGIM Jennison Value R6
AFAZX11.23N/A
N/A
Applied Finance Dividend Institutional

ALT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with CLDX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
+13.85%
CLDX - ALT
40%
Loosely correlated
+1.39%
VKTX - ALT
40%
Loosely correlated
+3.90%
CCCC - ALT
39%
Loosely correlated
+0.50%
KROS - ALT
39%
Loosely correlated
+0.96%
AMRN - ALT
38%
Loosely correlated
+0.93%
More